Human Mesenchymal Stem Cells as Mediators of Breast Carcinoma Tumorigenesis and Progression

por Rhodes, Lyndsay V., Burow, Matthew E.
Publicado 2010

Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk

por Rhodes, Lyndsay V, Antoon, James W, Muir, Shannon E, Elliott, Steven, Beckman, Barbara S, Burow, Matthew E
Publicado 2010

Insulin-Like Growth Factor-1 Signaling Regulates miRNA Expression in MCF-7 Breast Cancer Cell Line

por Martin, Elizabeth C., Bratton, Melyssa R., Zhu, Yun, Rhodes, Lyndsay V., Tilghman, Syreeta L., Collins-Burow, Bridgette M., Burow, Matthew E.
Publicado 2012

Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat

por Tate, Chandra R, Rhodes, Lyndsay V, Segar, H Chris, Driver, Jennifer L, Pounder, F Nell, Burow, Matthew E, Collins-Burow, Bridgette M
Publicado 2012

microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity

por Martin, Elizabeth C, Rhodes, Lyndsay V, Elliott, Steven, Krebs, Adrienne E, Nephew, Kenneth P, Flemington, Erik K, Collins-Burow, Bridgette M, Burow, Matthew E
Publicado 2014

Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways

por Strong, Amy L, Strong, Thomas A, Rhodes, Lyndsay V, Semon, Julie A, Zhang, Xiujuan, Shi, Zhenzhen, Zhang, Shijia, Gimble, Jeffrey M, Burow, Matthew E, Bunnell, Bruce A
Publicado 2013

Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration

por Zhou, Changhua, Zhong, Qiu, Rhodes, Lyndsay V, Townley, Ian, Bratton, Melyssa R, Zhang, Qiang, Martin, Elizabeth C, Elliott, Steven, Collins-Burow, Bridgette M, Burow, Matthew E, Wang, Guangdi
Publicado 2012

Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer

por Rhodes, Lyndsay V., Martin, Elizabeth C., Segar, H. Chris, Miller, David F. B., Buechlein, Aaron, Rusch, Douglas B., Nephew, Kenneth P., Burow, Matthew E., Collins-Burow, Bridgette M.
Publicado 2015

Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast c...

por Matossian, Margarite D., Elliott, Steven, Rhodes, Lyndsay V., Martin, Elizabeth C., Hoang, Van T., Burks, Hope E., Zuercher, William J., Drewry, David H., Collins-Burow, Bridgette M., Burow, Matthew E.
Publicado 2021

Endocrine Disruptor Regulation of MicroRNA Expression in Breast Carcinoma Cells

por Tilghman, Syreeta L., Bratton, Melyssa R., Segar, H. Chris, Martin, Elizabeth C., Rhodes, Lyndsay V., Li, Meng, McLachlan, John A., Wiese, Thomas E., Nephew, Kenneth P., Burow, Matthew E.
Publicado 2012

Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition

por ANTOON, JAMES W., NITZCHKE, ASHLEY M., MARTIN, ELIZABETH C., RHODES, LYNDSAY V., NAM, SEUNGYOON, WADSWORTH, SCOTT, SALVO, VIRGILO A., ELLIOTT, STEVEN, COLLINS-BUROW, BRIDGETTE, NEPHEW, KENNETH P., BUROW, MATTHEW E.
Publicado 2013

Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation

por Conger, Adrienne K., Martin, Elizabeth C., Yan, Thomas J., Rhodes, Lyndsay V., Hoang, Van T., La, Jacqueline, Anbalagan, Muralidharan, Burks, Hope E., Rowan, Brian G., Nephew, Kenneth P., Collins-Burow, Bridgette M., Burow, Matthew E.
Publicado 2016

Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance

por Antoon, James W., Lai, Rongye, Struckhoff, Amanda P., Nitschke, Ashley M., Elliott, Steven, Martin, Elizabeth C., Rhodes, Lyndsay V., Yoon, Nam Seung, Salvo, Virgilio A., Shan, Bin, Beckman, Barbara S., Nephew, Kenneth P., Burow, Matthew E.
Publicado 2012

Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers

por Strong, Amy L., Ohlstein, Jason F., Biagas, Brandi A., Rhodes, Lyndsay V., Pei, Dorothy T., Tucker, H. Alan, Llamas, Claire, Bowles, Annie C., Dutreil, Maria F., Zhang, Shijia, Gimble, Jeffrey M., Burow, Matthew E., Bunnell, Bruce A.
Publicado 2015

MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis

por Antoon, James W., Martin, Elizabeth C., Lai, Rongye, Salvo, Virgilo A., Tang, Yan, Nitzchke, Ashley M., Elliott, Steven, Nam, Seung Yoon, Xiong, Wei, Rhodes, Lyndsay V., Collins-Burow, Bridgette, David, Odile, Wang, Guandi, Shan, Bin, Beckman, Barbara S., Nephew, Kenneth P., Burow, Matthew E.
Publicado 2013

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model

por Matossian, Margarite D., Burks, Hope E., Elliott, Steven, Hoang, Van T., Bowles, Annie C., Sabol, Rachel A., Wahba, Bahia, Anbalagan, Muralidharan, Rowan, Brian, Abazeed, Mohamed E., Bunnell, Bruce A., Moroz, Krzysztof, Miele, Lucio, Rhodes, Lyndsay V., Jones, Steven D., Martin, Elizabeth C., Collins-Burow, Bridgette M., Burow, Matthew E.
Publicado 2019